Malavasi et al. showed that EVs released from BF01 myeloma cells in vitro express PD-L1 and the complement inhibitory receptors CD55 and CD59, but the relevance of this observation to the situation in vivo is not clear [13]. The gene discussed is CD59; the disease is plasma cell myeloma.